FEATURED COMPANIES
- Abcam PLC
- Agilent Technologies
- Becton
- Bio-Rad Laboratories
- Dickinson Co.pany
- F.Hoffmann-La Roche AG
A significant rise in research activities in the field of stem cells and neurobiology is one of the key factors stimulating the growth of the market.
Market Size - USD 3.35 Billion in 2019, Market Growth - CAGR of 5.9%, Market Trends - Increased funding for research and development activities
The Global Research Antibodies Market size was valued at USD 3.35 Billion in 2019 and is forecast to reach USD 5.33 Billion, exhibiting a CAGR of 5.9% through 2027, according to the latest report. Market growth is driven by a rise in research activities in the field of stem cells, along with the growing prevalence of neurological and blood disorders. The WHO estimates that nearly 27 million babies across the globe are born with some blood disorder. As of 2008, there were approximately 100,000 children suffering from thalassemia, an inherited blood disorder, in India alone.
Stem cell therapies are gaining massive popularity as they offer the potential for discerning and regenerating new cells in the human body, thereby curing or lessening the effect of life-threatening diseases like oncological and blood-related disorders. The cord blood stem cells offer the potential to treat over 80 blood-related ailments, such as leukemia, lymphomas, sickle cell disease, and others.
The rise in funding for R&D activities is positively impacting the research antibodies market. Over 2014 and 2017, the investment in healthcare R&D by the United States has witnessed a growth of 18.1%. Moreover, in 2017, the overall expenditure on healthcare R&D was USD 182.30 billion. The growing modality rate of cancer and other deadly diseases and demand for high-quality antibodies for research reproducibility will foster research antibodies market share over the forecast period.
Further key findings from the report suggest
For the purpose of this report, Reports and Data has segmented the Global Research Antibodies Market on the basis of product, antibody type, technology, application, industry vertical, and region:
Product Outlook (Revenue, USD Million; 2017-2027)
Antibody Type Outlook (Revenue, USD Million; 2017-2027)
Technology Outlook (Revenue, USD Million; 2017-2027)
Application Outlook (Revenue, USD Million; 2017-2027)
Industry Vertical Outlook (Revenue, USD Million; 2017-2027)
Regional Outlook (Revenue, USD Million; 2017-2027)
Reasons to Buy the Report
Market Size - USD 3.35 Billion in 2019, Market Growth - CAGR of 5.9%, Market Trends - Increased funding for research and development activities
The Global Research Antibodies Market size was valued at USD 3.35 Billion in 2019 and is forecast to reach USD 5.33 Billion, exhibiting a CAGR of 5.9% through 2027, according to the latest report. Market growth is driven by a rise in research activities in the field of stem cells, along with the growing prevalence of neurological and blood disorders. The WHO estimates that nearly 27 million babies across the globe are born with some blood disorder. As of 2008, there were approximately 100,000 children suffering from thalassemia, an inherited blood disorder, in India alone.
Stem cell therapies are gaining massive popularity as they offer the potential for discerning and regenerating new cells in the human body, thereby curing or lessening the effect of life-threatening diseases like oncological and blood-related disorders. The cord blood stem cells offer the potential to treat over 80 blood-related ailments, such as leukemia, lymphomas, sickle cell disease, and others.
The rise in funding for R&D activities is positively impacting the research antibodies market. Over 2014 and 2017, the investment in healthcare R&D by the United States has witnessed a growth of 18.1%. Moreover, in 2017, the overall expenditure on healthcare R&D was USD 182.30 billion. The growing modality rate of cancer and other deadly diseases and demand for high-quality antibodies for research reproducibility will foster research antibodies market share over the forecast period.
Further key findings from the report suggest
- Based on product type, the primary antibodies segment is forecast to grow at a CAGR of 6.2% over the analysis period. In immunoassays, primary antibodies are of major importance to bind to the target antigen.
- On the basis of technology, the western blotting segment is set to witness major gains over the forecast period on account of its capacity to detect picogram levels of protein in a sample, making it ideal for use in several applications as an effective early diagnostic tool. Additionally, it enables researchers to direct label primary antibodies, thereby eliminating the requirement for secondary antibodies.
- Based on application, the oncology segment contributed significantly to the market revenue share in 2019 and is expected to grow at a CAGR of 5.7% over the analysis period.
- In terms of end-use, the academics & research institutes segment held the second-largest market share of the research antibodies industry in 2019 and are likely to exhibit a CAGR of 5.2% through 2027.
- In the regional landscape, the Asia Pacific region is anticipated to experience the fastest growth rate of 7.1% through 2027 on account of the growth of the pharmaceutical industry, acceptance of innovative methods for antibody production, and surge in R&D activities for antibodies in the region, among others.
- Europe held the second-largest share in the research antibodies market share in 2019 and is forecast to exhibit a CAGR of 5.7% through 2027.
- North America is estimated to showcase a notable CAGR of 5.2% over the forecast period on account of the growing prevalence of blood diseases and neurological diseases, increased investment in medical R&D activities, technological advancements in proteomics research, growing demand for personalized medicine, and the presence of leading market players in the region.
- Prominent players in the global antibodies market are Becton, Lonza Group, Agilent Technologies, Dickinson and Company, Abcam PLC, Bio-Rad Laboratories, PerkinElmer, Inc., Merck Millipore, Thermo Fisher Scientific, Cell Signaling Technology Inc., and F.Hoffmann-La Roche AG, among others.
- Abcam PLC, a leading supplier of protein research tools, made an announcement in January 2020 regarding the acquisition of the Immunology & Proteomics business of Expedeon Ltd., comprising of TGR Biosciences and Innova.
For the purpose of this report, Reports and Data has segmented the Global Research Antibodies Market on the basis of product, antibody type, technology, application, industry vertical, and region:
Product Outlook (Revenue, USD Million; 2017-2027)
- Primary Antibodies
- Secondary Antibodies
Antibody Type Outlook (Revenue, USD Million; 2017-2027)
- Monoclonal
- Polyclonal
Technology Outlook (Revenue, USD Million; 2017-2027)
- Western Blotting
- Flow Cytometry
- Immunofluorescence
- Immunohistochemistry
- Enzyme-linked Immunosorbent Assay
- Immunoprecipitation
- Others
Application Outlook (Revenue, USD Million; 2017-2027)
- Oncology
- Infectious Diseases
- Stem Cells
- Neurobiology
- Immunology
- Others
Industry Vertical Outlook (Revenue, USD Million; 2017-2027)
- Pharmaceutical & Biopharmaceutical
- Academic & Research Institutes
- Contract Research Organizations
Regional Outlook (Revenue, USD Million; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Research Antibodies Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Research Antibodies market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abcam PLC
- Agilent Technologies
- Becton
- Bio-Rad Laboratories
- Dickinson Co.pany
- F.Hoffmann-La Roche AG
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 4. Research Antibodies Segmentation & Impact Analysis
Chapter 5. Research Antibodies Market By Product Insights & Trends
Chapter 6. Research Antibodies Market By Antibody Type Insights & Trends
Chapter 7. Research Antibodies Market By Technology & Trends
Chapter 8. Research Antibodies Market By Application Insights & Trends
Chapter 9. Research Antibodies Market By End-Users Insights & Trends
Chapter 10. Research Antibodies Market Regional Outlook
Chapter 11. Competitive Landscape
Chapter 12. Company Profiles
Note: Product cover images may vary from those shown
- Becton
- Dickinson Co.pany
- Lonza Group
- Agilent Technologies
- Abcam PLC
- PerkinElmer Inc.
- Bio-Rad Laboratories
- Merck Millipore
- F.Hoffmann-La Roche AG
- Thermo Fisher Scientific
- Cell Signaling Technology Inc.,
Note: Product cover images may vary from those shown
